Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stem cell
Pharma
FDA signs off on Omeros' stem cell transplant drug Yartemlea
The FDA has approved Omeros' Yartemlea as the first treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Kevin Dunleavy
Dec 26, 2025 12:46pm
ExCellThera's blood cancer cell therapy Zemcelpro earns EU nod
Aug 27, 2025 7:40am
Labcorp sticks up for stem cell donations in ‘Hero Gum’ campaign
Jul 25, 2025 12:32pm
NICE says no dice to Orchard's pricey therapy for rare disease
Jul 9, 2021 10:43am
Apceth Biopharma gets contract to manufacture Zynteglo
Jun 4, 2019 9:24am
Merck antiviral drug Prevymis wins NICE over
May 30, 2019 12:06pm
